Individuals with increased inflammatory response to ozone demonstrate muted signaling of immune cell trafficking pathways

Respiratory Research

Neil E Alexis²  David B Peden²  John C Lay²  Jenny Ting¹  June W Brickey¹  Baiming Zou³  Haibo Zhou³  Julia E Rager⁴  Rebecca C Fry⁴ 

[1] Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;Department of Pediatrics, University of North Carolina, School of Medicine University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA;Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA

关键词: Systems biology;    Innate immunity;    Immune response;    Human sputum;    Gene expression;    Ozone;    Environment;    Air pollution;   

Others  :  796637
DOI  :  10.1186/1465-9921-13-89

 received in 2012-06-29, accepted in 2012-09-21,  发布年份 2012

【 摘 要 】

Background

Exposure to ozone activates innate immune function and causes neutrophilic (PMN) airway inflammation that in some individuals is robustly elevated. The interplay between immuno-inflammatory function and genomic signaling in those with heightened inflammatory responsiveness to ozone is not well understood.

Objectives

Determine baseline predictors and post exposure discriminators for the immuno-inflammatory response to ozone in inflammatory responsive adult volunteers.

Methods

Sputum induction was performed on 27 individuals before and after a two hour chamber exposure to 0.4 ppm ozone. Subjects were classified as inflammatory responders or non-responders to ozone based on their PMN response. Innate immune function, inflammatory cell and cytokine modulation and transcriptional signaling pathways were measured in sputum.

Results

Post exposure, responders showed activated innate immune function (CD16: 31,004 MFI vs 8988 MFI; CD11b: 44,986 MFI vs 24,770 MFI; CD80: 2236 MFI vs 1506 MFI; IL-8: 37,603 pg/ml vs 2828 pg/ml; and IL-1β: 1380 pg/ml vs 318 pg/ml) with muted signaling of immune cell trafficking pathways. In contrast, non-responders displayed decreased innate immune activity (CD16, CD80; phagocytosis: 2 particles/PMN vs 4 particles/PMN) post exposure that was accompanied by a heightened signaling of immune cell trafficking pathways.

Conclusions

Inflammatory responsive and non responsive individuals to ozone show an inverse relationship between immune cell trafficking and immuno-inflammatory functional responses to ozone. These distinct genomic signatures may further our understanding about ozone-induced morbidity in individuals with different levels of inflammatory responsiveness.

【 授权许可】

   
2012 Fry et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Babin SM, Burkom HS, Holtry RS, Tabernero NR, Stokes LD, Davies-Cole JO, DeHaan K, Lee DH: Pediatric patient asthma-related emergency department visits and admissions in Washington, DC, from 2001–2004, and associations with air quality, socio-economic status and age group. Environ Health 2007, 6:9. BioMed Central Full Text
• [2]Fauroux B, Sampil M, Quénel P, Lemoullec Y: Ozone: a trigger for hospital pediatric asthma emergency room visits. Pediatr Pulmonol 2000, 30:41-46.
• [3]Hiltermann TJ, Peters EA, Alberts B, Kwikkers K, Borggreven PA, Hiemstra PS, Dijkman JH, van Bree LA, Stolk J: Ozone-induced airway hyperresponsiveness in patients with asthma: role of neutrophil-derived serine proteinases. Free Radic Biol Med 1998, 24:952-958.
• [4]Kehrl HR, Peden DB, Ball B, Folinsbee LJ, Horstman D: Increased specific airway reactivity of persons with mild allergic asthma after 7.6 hours of exposure to 0.16 ppm ozone. J Allergy Clin Immunol 1999, 104:1198-1204.
• [5]Molfino NA, Wright SC, Katz I, Tarlo S, Silverman F, McClean PA, Szalai JP, Raizenne M, Slutsky AS, Zamel N: Effect of low concentrations of ozone on inhaled allergen responses in asthmatic subjects. Lancet 1991, 338:199-203.
• [6]EPA: Air quality criteria for ozone and related photochemical oxidants (2006 final). US: Environmental Protection Agency; 2006. [Book Air quality criteria for ozone and related photochemical oxidants (2006 final). (Editor ed.^eds.), vol. I. City]
• [7]Schwela D: Air pollution and health in urban areas. Rev Environ Health 2000, 15:13-42.
• [8]Alexis NE, Lay JC, Hazucha M, Harris B, Hernandez ML, Bromberg PA, Kehrl H, Diaz-Sanchez D, Kim C, Devlin RB, Peden DB: Low-level ozone exposure induces airways inflammation and modifies cell surface phenotypes in healthy humans. Inhal Toxicol 2010, 22:593-600.
• [9]Kim CS, Alexis NE, Rappold AG, Kehrl H, Hazucha MJ, Lay JC, Schmitt MT, Case M, Devlin RB, Peden DB, Diaz-Sanchez D: Lung function and inflammatory responses in healthy young adults exposed to 0.06 ppm ozone for 6.6 hours. Am J Respir Crit Care Med 2011, 183:1215-1221.
• [10]Alexis NE, Zhou H, Lay JC, Harris B, Hernandez ML, Lu TS, Bromberg PA, Diaz-Sanchez D, Devlin RB, Kleeberger SR, Peden DB: The glutathione-S-transferase Mu 1 null genotype modulates ozone-induced airway inflammation in human subjects. J Allergy Clin Immunol 2009, 124:1222-1228.
• [11]Bauer AK, Travis EL, Malhotra SS, Rondini EA, Walker C, Cho HY, Trivedi S, Gladwell W, Reddy S, Kleeberger SR: Identification of novel susceptibility genes in ozone-induced inflammation in mice. Eur Respir J 2009, 36:428-437.
• [12]Alexis NE, Lay JC, Haczku A, Gong H, Linn W, Hazucha MJ, Harris B, Tal-Singer R, Peden DB: Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers. Environ Health Perspect 2008, 116:799-805.
• [13]Lazaar AL, Sweeney LE, MacDonald AJ, Alexis NE, Chen C, Tal-Singer R: SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans. Br J Clin Pharmacol 2011, 72:282-293.
• [14]Holz O, Khalilieh S, Ludwig-Sengpiel A, Watz H, Stryszak P, Soni P, Tsai M, Sadeh J, Magnussen H: SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects. Eur Respir J 2009, 35:564-570.
• [15]Alexis NE, Hu SC, Zeman K, Alter T, Bennett WD: Induced sputum derives from the central airways: confirmation using a radiolabeled aerosol bolus delivery technique. Am J Respir Crit Care Med 2001, 164:1964-1970.
• [16]Hu SC, Ben-Jebria A, Ultman JS: Longitudinal distribution of ozone absorption in the lung: effects of respiratory flow. J Appl Physiol 1994, 77:574-583.
• [17]Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al.: Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
• [18]Cleveland WS: Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979, 74:829-836.
• [19]Zhang Y, Szustakowski J, Schinke M: Bioinformatics analysis of microarray data. Methods Mol Biol 2009, 573:259-284.
• [20]Becker RA, Chambers JM, Wilks AR: The new S language. New York: Chapman & Hall; 1988.
• [21]Palmer C, Diehn M, Alizadeh AA, Brown PO: Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics 2006, 7(115):1-15.
• [22]Fry RC, Svensson JP, Valiathan C, Wang E, Hogan BJ, Bhattacharya S, Bugni JM, Whittaker CA, Samson LD: Genomic predictors of interindividual differences in response to DNA damaging agents. Genes Dev 2008, 22:2621-2626.
• [23]McConnell R, Berhane K, Gilliland F, London SJ, Islam T, Gauderman WJ, Avol E, Margolis HG, Peters JM: Asthma in exercising children exposed to ozone: a cohort study. Lancet 2002, 359:386-391.
• [24]Alexeeff SE, Litonjua AA, Suh H, Sparrow D, Vokonas PS, Schwartz J: Ozone exposure and lung function: effect modified by obesity and airways hyperresponsiveness in the VA normative aging study. Chest 2007, 132:1890-1897.
• [25]Laskin DL, Sunil V, Guo Y, Heck DE, Laskin JD: Increased nitric oxide synthase in the lung after ozone inhalation is associated with activation of NF-kappa B. Environ Health Perspect 1998, 106(Suppl 5):1175-1178.